Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.80% | 63.94 | 1.0% | $438.87m | |
| AMGN | Amgen, Inc. | -0.72% | 235.04 | 1.3% | $415.03m | |
| BIIB | Biogen, Inc. | -1.35% | 284.21 | 1.4% | $361.86m | |
| ILMN | Illumina, Inc. | -1.21% | 327.00 | 3.5% | $319.37m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.30% | 233.91 | 1.9% | $274.07m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.71% | 356.60 | 2.6% | $229.47m | |
| EXAS | EXACT Sciences Corp. | -2.93% | 92.18 | 24.0% | $223.58m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.56% | 108.55 | 2.0% | $165.88m | |
| INCY | Incyte Corp. | -0.31% | 78.24 | 2.5% | $128.46m | |
| A | Agilent Technologies, Inc. | -1.23% | 89.02 | 1.6% | $123.04m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.93% | 113.68 | 14.6% | $106.56m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -2.24% | 85.63 | 4.3% | $104.31m | |
| SGEN | Seattle Genetics, Inc. | 3.27% | 115.35 | 6.1% | $95.31m | |
| BLUE | bluebird bio, Inc. | -4.35% | 89.72 | 14.2% | $89.28m | |
| ITCI | Intra-Cellular Therapies, Inc. | -2.59% | 24.86 | 9.0% | $84.71m |
Company Profile
Pluristem Therapeutics, Inc. engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. It focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.